15.04.2024 13:59:32

Ocular Therapeutix CEO Mattessich To Step Down, Dugel To Succeed

(RTTNews) - Ocular Therapeutix, Inc. (OCUL) announced on Monday that President and CEO Antony Mattessich will be stepping down.

Mattessich is being succeeded by Pravin Dugel, executive chairman, who will assume the roles of president and CEO, effective immediately.

In addition to these new responsibilities, Dugel will maintain his positions as a director and executive chairman of the company.

Dugel has previously served in leadership roles such as President of Iveric Bio, Inc.

Analysen zu Ocular Therapeutix Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Ocular Therapeutix Inc 8,04 0,07% Ocular Therapeutix Inc